Canada to Lift Flavor Ban on E-Cigarettes After 3 Years

Regulations by 2FIRSTS.ai
Apr.12.2024
Canada to Lift Flavor Ban on E-Cigarettes After 3 Years
Canada to lift 3-year flavor ban on e-cigarettes, requiring manufacturers to use approved ingredients, sparking backlash from consumers.

According to a report by Vaping360 on April 11th, Canada will lift the 3-year-old ban on flavored e-cigarettes. The ban was initially approved by the government in June 2021 but has been dormant ever since.

 

According to the regulation, Health Canada will provide manufacturers with a list of up to 100 permitted flavoring ingredients and mandate that only these ingredients can be used to make e-liquid, but only for tobacco, menthol, and mint flavors.

 

At the same time, the use of any type of sweeteners is strictly prohibited. The agency stated in 2021 that an estimated 80-85% of existing products will need to be reformulated to meet the new requirements. Additionally, the regulation will specify "sensory attribute standards to prevent sensations other than those typical of tobacco or mint/menthol from being perceived." In other words, manufacturers will not be able to add caramel to tobacco flavors, or fruit flavors to mint flavors.

 

Five provinces in Canada have already banned flavored e-cigarettes. Quebec has been enforcing the ban since last October, while New Brunswick, Nova Scotia, the Northwest Territories, and Prince Edward Island have implemented similar regulations. Nunavut has also passed the ban, but has not yet set a specific implementation date. However, despite these flavor bans being in place, over 70% of Canadians can still purchase flavored e-cigarettes.

 

Canadian Health Minister Mark Holland is vigorously pushing to lift the long-standing ban, with support from the Heart and Stroke Foundation, the Canadian Cancer Society, the Canadian Lung Association, and some smaller anti-tobacco non-governmental organizations.

 

During a recent press conference, Holland stated: "I have previously collaborated with the Heart and Stroke Foundation to address the issue of e-cigarettes. At that time, when the information was uncertain, they advised that e-cigarettes be seen as a smoking cessation tool rather than taking action. Unfortunately, this led to the tobacco industry attracting a group of young people who had never been exposed to nicotine to something that threatens their health. This has had extremely adverse consequences for our healthcare system." Canadian e-cigarette consumers have expressed that the ban will have a destructive impact on the legal consumption of e-cigarettes and will cause irreversible harm to the independent e-cigarette industry. Canada has around 1.8 million e-cigarette users, with the majority preferring flavors that are not permitted by the health department. The proposed regulations will force many people to return to smoking and create a vibrant disposable e-cigarette "black market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
IQOS UK unveils 2026 pop-up events plan, first stops set for London and three other cities
IQOS UK unveils 2026 pop-up events plan, first stops set for London and three other cities
IQOS’ UK website shows the company will roll out time-limited pop-up experience spaces across Britain in 2026 for adult consumers. The first confirmed locations are London, the West Midlands area near Birmingham, Manchester and Romford, offering product demonstrations, pop-up-only promotions and nicotine pouch sampling. Entry will be restricted to those aged 18 and over, with “Challenge 25” ID checks in place.
Feb.03 by 2FIRSTS.ai
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
VOOPOO’s website shows the company has introduced the NAVI×Cyph Kit 80K, an open-system, refillable vaping kit claimed to deliver up to 80,000 puffs. The device features a 1,500mAh battery with USB Type-C charging and comes in 12 flavors. A promotional image posted on VOOPOO’s official Instagram account includes the phrase “E-LIQUID BUILT IN THE USA.”
Feb.10 by 2FIRSTS.ai
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
British American Tobacco is facing a shareholder lawsuit in London alleging it failed to properly disclose to markets information about breaches of U.S. sanctions linked to its North Korea-related business. BAT agreed in 2023 to pay more than $635 million to U.S. authorities after a subsidiary admitted conspiring to violate U.S. sanctions by selling tobacco products to North Korea and committing bank fraud from 2007 to 2017.
Mar.05 by 2FIRSTS.ai
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Data shows 75% of nations with state stakes in tobacco trade ban modern substitutes compared to 10% in the free-market group. What is driving these divergent regulations?
Feb.04
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24